Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

STOK Stoke Therapeutics, Inc.

交易中 09-15 13:03:19 EDT

28.21

-1.39

-4.70%

最高29.56	最低27.82	成交量70.07万
今开29.56	昨收29.60	日振幅5.88%
总市值18.20亿	流通市值13.83亿	总股本6,453万
成交额1,994万	换手率1.43%	流通股本4,901万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"STOK","market":"US","secType":"STK","nameCN":"Stoke Therapeutics, Inc.","latestPrice":28.21,"timestamp":1789491798827,"preClose":29.6,"halted":0,"volume":700734,"delay":0,"changeRate":-0.04695945945945948,"floatShares":49012700,"shares":64526200,"eps":-3.33249,"marketStatus":"交易中","change":-1.39,"latestTime":"09-15 13:03:19 EDT","open":29.56,"high":29.56,"low":27.82,"amount":19936432.37619,"amplitude":0.058784,"askPrice":28.22,"askSize":200,"bidPrice":28.15,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-3.33249,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"listingDate":1560916800000,"exchange":"NASDAQ","adjPreClose":29.6,"preHourTrading":{"tag":"盘前","latestPrice":29.9,"preClose":29.6,"latestTime":"04:22 EDT","volume":2,"amount":59.84,"timestamp":1789460560071,"change":0.3,"changeRate":0.010135,"amplitude":0.001351},"postHourTrading":{"tag":"盘后","latestPrice":29.6,"preClose":29.6,"latestTime":"19:30 EDT","volume":84218,"amount":2492852.8,"timestamp":1789428602670,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.235393,"impliedVol":0.5481,"impliedVolPercentile":0.0797},"requestUrl":"/m/hq/s/STOK","defaultTab":"news","newsList":[{"id":"1194645441","title":"Stoke Therapeutics与渤健在第16届欧洲癫痫大会上公布Zorevunersen长期临床数据，力证Dravet综合征治疗药物的疾病修饰潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194645441","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194645441?lang=zh_cn&edition=full","pubTime":"2026-09-04 07:31","pubTimestamp":1788478271,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics与渤健公司于第16届欧洲癫痫大会上联合呈现了Zorevunersen的长期临床数据，这些数据有力支持了这款用于治疗Dravet综合征的在研药物所具备的疾病修饰潜力。Zorevunersen作为一种实验性疗法，其最新公布的长期随访结果备受业界关注。此次大会上披露的数据，进一步印证了该药物在改变Dravet综合征疾病进程方面的可能性，为这一罕见且严重的癫痫性脑病治疗领域带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","LU0320765992.SGD","STOK","BK4585","LU0109394709.USD","BK4588","BIIB","PBE","BK4533","BK4139","LU0889565916.HKD","BK4532","LU0234570918.USD","IE00B894F039.SGD","IE00B19Z9Z06.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170325153","title":"Stoke Therapeutics宣布Dravet综合征在研药物Zorevunersen III期EMPEROR研究完成162名患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1170325153","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170325153?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:27","pubTimestamp":1783322842,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics, Inc. 宣布，其用于治疗Dravet综合征的在研药物Zorevunersen的III期EMPEROR研究已完成患者入组工作，共计招募162名患者。该公司计划于2027年第一季度启动向美国食品药品监督管理局（FDA）滚动提交新药申请（NDA）的程序。关键的III期临床数据预计将在2027年第三季度读出，并计划在2027年下半年完成NDA的全部提交。值得注意的是，在该III期EMPEROR研究中，目前尚无患者中止治疗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151035407","title":"Stoke Therapeutics：关键III期数据预计2027年第三季度揭晓，新药申请拟于下半年提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1151035407","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151035407?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:03","pubTimestamp":1782821003,"startTime":"0","endTime":"0","summary":"生物技术公司 Stoke Therapeutics 近日披露了其研发管线的重要时间表。备受关注的关键性III期临床试验数据，预计将于2027年第三季度获得最终结果。紧随其后，公司计划在2027年下半年完成向监管机构提交新药上市申请（NDA）的工作。\n这一进展标志着该公司在研疗法向商业化迈出了关键一步。市场分析人士普遍关注该时间节点的数据表现，因其将直接影响该疗法的获批前景及公司未来的市场估值。投资者将密切关注后续进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STOK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115476844","title":"斯托克治疗公司宣布Dravet综合征在研药物Zorevunersen III期EMPEROR研究完成162名患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1115476844","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115476844?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:01","pubTimestamp":1782820895,"startTime":"0","endTime":"0","summary":"斯托克治疗公司宣布，其针对Dravet综合征的在研药物Zorevunersen，其III期关键临床试验EMPEROR研究已完成全部162名患者的入组工作。这一里程碑标志着该候选疗法向潜在上市又迈进了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","STOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189126936","title":"异动解读 | 获分析师大幅上调目标价，Stoke Therapeutics盘中大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189126936","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189126936?lang=zh_cn&edition=full","pubTime":"2026-03-20 21:45","pubTimestamp":1774014321,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics, Inc.（STOK）今日盘中股价大涨5.39%，引起了市场的关注。消息面上，根据路透报道，华尔街券商Canaccord Genuity将Stoke Therapeutics的目标价从36美元大幅上调至60美元。分析师上调目标价通常被视为对公司未来前景的积极看法，这可能是推动股价上涨的主要原因。此次目标价上调幅度显著，反映了分析师对该公司基本面的乐观预期，从而提振了投资者的信心，并在交易时段内推动了股价的上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["STOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512481552","title":"Stoke Therapeutics, Inc.盘中异动 股价大跌5.05%报9.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512481552?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:49","pubTimestamp":1739980170,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时49分，Stoke Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。截至发稿，该股报9.22美元/股，成交量25.0385万股，换手率0.47%，振幅6.75%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219234931abd50f55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219234931abd50f55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STOK","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512031081","title":"Chardan Capital：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由24.00美元调整至24.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512031081","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512031081?lang=zh_cn&edition=full","pubTime":"2025-02-19 19:41","pubTimestamp":1739965272,"startTime":"0","endTime":"0","summary":"Chardan Capital：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由24.00美元调整至24.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19194148264816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["STOK","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512193780","title":"HC Wainwright & Co.：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至47.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193780","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512193780?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:21","pubTimestamp":1739902892,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至47.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19022148243309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","STOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512167390","title":"Stoke Therapeutics, Inc.盘中异动 临近午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512167390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512167390?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:44","pubTimestamp":1739897053,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时44分，Stoke Therapeutics, Inc.股票出现异动，股价快速下跌5.02%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为404.41%、180.64%、152.15%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219004413abd3cb9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219004413abd3cb9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510860954","title":"Stoke Therapeutics, Inc.盘中异动 股价大跌5.02%报10.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510860954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510860954?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:06","pubTimestamp":1739207178,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时06分，Stoke Therapeutics, Inc.股票出现波动，股价大幅下挫5.02%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2924.99%、1588.47%、1149.27%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010619a240c260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010619a240c260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","STOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509278127","title":"Stoke Therapeutics, Inc.盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509278127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509278127?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:24","pubTimestamp":1738952640,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时24分，Stoke Therapeutics, Inc.股票出现异动，股价急速下跌5.10%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Conduit Pharmaceuticals Inc.、Sionna Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为7668.46%、173.84%、123.00%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、53.38%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022401abc65c16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022401abc65c16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508310463","title":"Stoke Therapeutics, Inc.盘中异动 早盘大幅上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508310463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508310463?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:06","pubTimestamp":1738681573,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时06分，Stoke Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1414.21%、852.16%、218.57%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为60.25%、49.88%、40.00%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042306139617dd69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042306139617dd69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","STOK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507672598","title":"Stoke Therapeutics, Inc.盘中异动 下午盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507672598?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:12","pubTimestamp":1738264336,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时12分，Stoke Therapeutics, Inc.股票出现异动，股价快速上涨5.14%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1785.55%、301.33%、242.74%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、64.10%、61.86%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310312169876cfdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310312169876cfdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","STOK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505771354","title":"Stoke Therapeutics, Inc.盘中异动 急速拉升5.00%报10.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505771354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505771354?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:54","pubTimestamp":1737568489,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时54分，Stoke Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为977.42%、307.75%、76.95%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 、Nutriband Inc C/Wts ，振幅分别为60.53%、53.51%、50.39%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123015450960d201f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123015450960d201f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STOK","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503916051","title":"Stoke Therapeutics, Inc.盘中异动 股价大跌5.06%报9.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503916051?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:03","pubTimestamp":1737039839,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时03分，Stoke Therapeutics, Inc.股票出现波动，股价大幅下挫5.06%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aditxt, Inc.、Palisade Bio, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1650.68%、359.28%、232.75%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aditxt, Inc.、Channel Therapeutics Corporation，振幅分别为131.33%、61.60%、55.47%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623040098689301&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623040098689301&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503635728","title":"Stoke Therapeutics, Inc.盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503635728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503635728?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:40","pubTimestamp":1736887211,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时40分，Stoke Therapeutics, Inc.股票出现异动，股价快速下跌5.16%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1092.63%、613.28%、423.63%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115044011abaafd6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115044011abaafd6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502277044","title":"Stoke Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报8.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502277044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502277044?lang=zh_cn&edition=full","pubTime":"2025-01-09 00:05","pubTimestamp":1736352331,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日00时05分，Stoke Therapeutics, Inc.股票出现波动，股价急速下跌5.05%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为3140.85%、579.14%、556.49%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为192.73%、139.44%、88.32%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109000531a21a6956&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109000531a21a6956&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","STOK","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501980789","title":"Stoke Therapeutics, Inc.盘中异动 早盘快速下挫7.55%报10.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501980789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501980789?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:31","pubTimestamp":1736260313,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时31分，Stoke Therapeutics, Inc.股票出现异动，股价快速跳水7.55%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Hoth Therapeutics, Inc.、Immuneering Corporation、Conduit Pharmaceuticals Inc.涨幅较大，Hoth Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃，换手率分别为726.40%、161.92%、95.97%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Immuneering Corporation，振幅分别为25.62%、21.99%、14.83%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223153aba1df0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107223153aba1df0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","STOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500997599","title":"Stoke Therapeutics, Inc.盘中异动 早盘快速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500997599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500997599?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:54","pubTimestamp":1735833288,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时54分，Stoke Therapeutics, Inc.股票出现波动，股价快速拉升5.08%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Mustang Bio, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Revelation Biosciences, Inc.、知临集团、Mustang Bio, Inc.较为活跃，换手率分别为1134.63%、141.89%、55.31%，振幅较大的相关个股有Revelation Biosciences, Inc.、Mustang Bio, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为127.98%、113.33%、98.57%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010223544895f6a8bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010223544895f6a8bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["STOK","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492180823","title":"Stoke Therapeutics, Inc.盘中异动 大幅跳水5.04%报11.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492180823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492180823?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:07","pubTimestamp":1734534428,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时07分，Stoke Therapeutics, Inc.股票出现异动，股价快速下挫5.04%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1936.91%、406.24%、278.01%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、96.72%、66.83%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过使用基于 RNA 的药物上调蛋白质表达来解决严重疾病的根本原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823070895ea55a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823070895ea55a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","STOK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.stoketherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0534},{"period":"3month","weight":0.0154},{"period":"6month","weight":-0.0458},{"period":"1year","weight":0.2617},{"period":"ytd","weight":-0.0674}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Stoke Therapeutics, Inc.成立于2014年6月，根据特拉华州法律注册成立。该公司是一家专注于通过RNA药物上调蛋白表达以解决严重疾病根本病因的临床后期阶段企业。凭借其专有的TANGO（靶向增强核基因输出）技术平台，公司致力于开发反义寡核苷酸药物以选择性恢复蛋白质水平。其领先的在研药物zorevunersen(STK-001)是一种具有疾病修饰潜力的疗法，目前正处于治疗重症进行性遗传性癫痫——Dravet综合征的临床后期试验阶段。公司重点关注单倍剂量不足相关疾病以及中枢神经系统和眼科疾病，其技术理念已在多个生物系统中得到概念验证。在拥有人类遗传学、RNA调控及罕见病药物开发领域丰富经验的管理团队带领下，公司持续推进其创新疗法管线。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.03437},{"month":2,"riseRate":0.428571,"avgChangeRate":0.03862},{"month":3,"riseRate":0.285714,"avgChangeRate":0.010836},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.029601},{"month":5,"riseRate":0.571429,"avgChangeRate":0.127033},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.011064},{"month":7,"riseRate":0.5,"avgChangeRate":-0.047644},{"month":8,"riseRate":0.625,"avgChangeRate":0.131907},{"month":9,"riseRate":0.25,"avgChangeRate":-0.09721},{"month":10,"riseRate":0.714286,"avgChangeRate":0.110002},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.025248},{"month":12,"riseRate":0.714286,"avgChangeRate":0.122564}],"exchange":"NASDAQ","name":"Stoke Therapeutics, Inc.","nameEN":"Stoke Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Stoke Therapeutics, Inc.,STOK,Stoke Therapeutics, Inc.股票,Stoke Therapeutics, Inc.股票老虎,Stoke Therapeutics, Inc.股票老虎国际,Stoke Therapeutics, Inc.行情,Stoke Therapeutics, Inc.股票行情,Stoke Therapeutics, Inc.股价,Stoke Therapeutics, Inc.股市,Stoke Therapeutics, Inc.股票价格,Stoke Therapeutics, Inc.股票交易,Stoke Therapeutics, Inc.股票购买,Stoke Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}